Dr Mathew Garnett
Mesobank is collaborating with the Wellcome Sanger Institute Garnett lab on the development and genomic characterisation of pleural mesothelioma organoid models.  This work is funded through a project grant from Asthma and Lung UK (formerly the British Lung Foundation).

Professors William Cookson and Miriam Moffatt, Imperial College London
Mesobank is a major supporter of the National Mesothelioma Research Centre (NMRC) at Imperial College supplying mesothelioma samples for the NMRC genomic research programme.

Professor George Malliaras, University of Cambridge
We are working with a consortium led by Professor Malliaras to study novel drug delivery methods in three hard-to-treat cancers, one of which is mesothelioma.  The programme is funded by the Engineering and Physical Sciences Research Council.

Professor Kevin Blyth, University of Glasgow
Professor Blyth is leading the PREDICT-Meso study (PRE-malignant Drivers Combined with Target-Drug validation in Mesothelioma) funded through CRUK’s Accelerator scheme together with the Fondazione AIRC and the Fundación Científica de la Asociación Española Contra el Cáncer for a period of 5 years. The research programme aims to close the gap on identifying key molecular events in the early stages of disease by focussing on understanding how asbestos-driven inflammation develops into MPM.  Mesobank will be supplying paired pre-malignant benign pleural tissue and subsequent mesothelioma samples.

Professor Judy Coulson, University of Liverpool
Through a NC3R grant (National Centre for the Replacement, Reduction and Refinement of animals in research), Professor Coulson is developing a chick embryo model to aid in the development of personalised therapies for mesothelioma.  Mesobank is supplying mesothelioma tissue for this programme of research.

Dr Luke Wylie
Dr Wylie, who is based at the Wellcome Trust Sanger Institute, is studying the mutational landscape of non-malignant pleura following asbestos exposure. This work is funded through a project grant from Asthma and Lung UK (formerly the British Lung Foundation).